EFTA02431807.pdf
PDF Source (No Download)
Extracted Text (OCR)
To:
From:
Sent:
Subject: Ida
[Code of Federal Regulations)
[Title 21, Volume 8]
[Revised as of April 1, 2009)
(CITE: 21CFR1271.10]
jeevacation©gmail.com[jeevacation@gmail.com]
Thur 1/21/2010 3:18:16 PM
TITLE 21--FOOD AND DRUGS
CHAPTER I--FOOD AND DRUG ADMINISTRATION
DEPARTMENT OF HEALTH AND HUMAN SERVICES
SUBCHAPTER L--REGULATIONS UNDER CERTAIN OTHER ACTS ADMINISTERED BY
THE FOOD AND DRUG ADMINISTRATION
PART 1271 -- HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED
PRODUCTS
Subpart A--General Provisions
Sec. 1271.10 Are my HCT/P's regulated solely under section 361 of the PHS Act
and the regulations in this part, and if so what must I do?
(a) An HCT/P is regulated solely under section 361 of the PHS Act and the
regulations in this part if it meets all of the following criteria:
EFTA_R1_01502303
EFTA02431807
(1) The HCl/P is minimally manipulated;
(2) The HCT/P is intended for homologous use only, as reflected by the labeling,
advertising, or other indications of the manufacturer's objective intent;
(3) The manufacture of the HCT/P does not involve the combination of the cells
or tissues with another article, except for water, crystalloids, or a sterilizing,
preserving, or storage agent, provided that the addition of water, crystalloids, or
the sterilizing, preserving, or storage agent does not raise new clinical safety
concerns with respect to the HCT/P; and
(4) Either:
(i) The HCT/P does not have a systemic effect and is not dependent upon the
metabolic activity of living cells for its primary function; or
(ii) The HCT/P has a systemic effect or is dependent upon the metabolic activity
of living cells for its primary function, and:
(a ) Is for autologous use;
) Is for allogeneic use in a first-degree or second-degree blood relative; or
(c ) Is for reproductive use.
(b) If you are a domestic or foreign establishment that manufactures an HCT/P
described in paragraph (a) of this section:
(1) You must register with FDA;
(2) You must submit to FDA a list of each HCT/P manufactured; and
(3) You must comply with the other requirements contained in this part.
[66 FR 5466, Jan. 19, 2001, as amended at 69 FR 68681, Nov. 24, 2004]
[Code of
Federal
Regulations]
EFTA_R1_01502304
EFTA02431808
Sincerely,
%tits, Wain, M.D.
VICTOR DERMATOLOGY AND REJUVENATION
LASERSCULPT, INC
30 EAST 76TH STREET
111111
AHelp save paper not printing if not needed
EFTA_R1_01502305
EFTA02431809
Document Preview
PDF source document
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
Extracted Information
Email Addresses
Document Details
| Filename | EFTA02431807.pdf |
| File Size | 179.4 KB |
| OCR Confidence | 85.0% |
| Has Readable Text | Yes |
| Text Length | 2,462 characters |
| Indexed | 2026-02-12T16:57:58.228632 |